Phage therapy for a long-term joint replacement infection
Treatments studied
Part of Bones, joints & muscles, Infections clinical trials.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a chronic infection around a joint replacement (prosthetic joint).
- You must have already tried multiple surgeries and medications that did not clear the infection.
- You must be willing to sign a consent form to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to prevent infections for people getting a hip or knee replacement. It compares different methods to see which works best and may help lower your risk of infection after surgery.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
This trial studies a treatment using viruses that attack bacteria (called phages) to fight a stubborn joint infection that hasn't improved with other treatments. It may help people with chronic infections that resist antibiotics.
This study tests whether adding a treatment with special viruses (called phages) to standard antibiotic care can help clear a joint infection more effectively after surgery. The goal is to improve your chances of keeping the artificial hip or knee and avoid the need for more procedures.
This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.
This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.
Hear when a new Periprosthetic Joint Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.